Back to STRS OHIO STRS OHIO

GYREGYRE
5 quarters

Position history for STRS OHIOSTRS OHIO's holdings in GYRE THERAPEUTICS INC

Yes. STRS Ohio holds 25,800 shares of GYRE (Gyre Therapeutics), worth $170,022, as of its Q2 2026 13F filing. It increased the position by 4,700 shares (+22.3%) from Q1 2026. STRS Ohio has held GYRE since Q2 2025, across 5 quarterly 13F filings.

Current Value

$170,022

Current Shares

25,800

Total Value Change

+$72,267

Total Shares Change

+12,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
25,800
+22.3%
$170,0220.0%$6.59
27
2026-Q1
Unchanged
21,100
0.0%
$147,0670.0%$6.97
0
2025-Q4
Unchanged
21,100
0.0%
$148,9660.0%$7.06
0
2025-Q3
Increased
21,100
+58.6%
$157,4060.0%$7.46
32
2025-Q2
New
13,300
-
$97,7550.0%$7.35
30

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used